[
    [
        {
            "time": "2020-04-14",
            "original_text": "格隆汇港股聚焦(4.14)︱中国人寿一季度保费收入3078亿元小米耗资2.5亿港元回购2455万股",
            "features": {
                "keywords": [
                    "中国人寿",
                    "保费收入",
                    "小米",
                    "回购"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "保险",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(4.14)︱中国人寿一季度保费收入3078亿元小米耗资2.5亿港元回购2455万股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "复星医药：子公司获药品补充申请批件 新药适用于类风湿关节炎等治疗",
            "features": {
                "keywords": [
                    "复星医药",
                    "药品补充申请",
                    "类风湿关节炎"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：子公司获药品补充申请批件 新药适用于类风湿关节炎等治疗",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "晚间公告热点追踪：中信证券澄清与中信建投合并传闻",
            "features": {
                "keywords": [
                    "中信证券",
                    "中信建投",
                    "合并传闻"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "晚间公告热点追踪：中信证券澄清与中信建投合并传闻",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "复星医药(02196)：复宏汉霖拟为汉霖制药不超过2亿元贷款提供担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "贷款担保"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药(02196)：复宏汉霖拟为汉霖制药不超过2亿元贷款提供担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "两种新冠病毒灭活疫苗进入临床试验 国产疫苗研发加速推进",
            "features": {
                "keywords": [
                    "新冠病毒",
                    "灭活疫苗",
                    "临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两种新冠病毒灭活疫苗进入临床试验 国产疫苗研发加速推进",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "复星医药(02196)子公司收到关于利妥昔单抗注射液的药品补充申请批件",
            "features": {
                "keywords": [
                    "复星医药",
                    "利妥昔单抗",
                    "药品补充申请"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196)子公司收到关于利妥昔单抗注射液的药品补充申请批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "医药生物行业今日涨1.74%，主力资金净流出4.50亿元",
            "features": {
                "keywords": [
                    "医药生物",
                    "主力资金",
                    "净流出"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业今日涨1.74%，主力资金净流出4.50亿元",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "恒指冲高回落收涨0.56% 医药板块活跃",
            "features": {
                "keywords": [
                    "恒指",
                    "医药板块",
                    "活跃"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒指冲高回落收涨0.56% 医药板块活跃",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-14",
            "original_text": "国药集团武汉所研发 全球首个新冠病毒灭活疫苗进入临床",
            "features": {
                "keywords": [
                    "国药集团",
                    "新冠病毒",
                    "灭活疫苗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国药集团武汉所研发 全球首个新冠病毒灭活疫苗进入临床",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]